290 related articles for article (PubMed ID: 28752351)
21. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang Z; Gu JH; Guo CS; Li XH; Yang WC
Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.
Chen J; Deng Q; Pan Y; He B; Ying H; Sun H; Liu X; Wang S
FEBS Open Bio; 2015; 5():502-7. PubMed ID: 26137435
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.
Gu X; Gao X; Li X; Qi X; Ma M; Qin S; Yu H; Sun S; Zhou D; Wang W
Sci Rep; 2016 Feb; 6():22089. PubMed ID: 26912340
[TBL] [Abstract][Full Text] [Related]
24. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
D'Andrea D; Moschini M; Gust KM; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
J Surg Oncol; 2017 Mar; 115(4):455-461. PubMed ID: 28105663
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.
D'Andrea D; Moschini M; Gust K; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
Clin Genitourin Cancer; 2017 Oct; 15(5):e755-e764. PubMed ID: 28420564
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.
Li MX; Liu XM; Zhang XF; Zhang JF; Wang WL; Zhu Y; Dong J; Cheng JW; Liu ZW; Ma L; Lv Y
Int J Cancer; 2014 May; 134(10):2403-13. PubMed ID: 24122750
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis.
Zou P; Yang E; Li Z
Sci Rep; 2020 Dec; 10(1):21917. PubMed ID: 33318608
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Templeton AJ; McNamara MG; Šeruga B; Vera-Badillo FE; Aneja P; Ocaña A; Leibowitz-Amit R; Sonpavde G; Knox JJ; Tran B; Tannock IF; Amir E
J Natl Cancer Inst; 2014 Jun; 106(6):dju124. PubMed ID: 24875653
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of NLR in urinary cancers: a meta-analysis.
Wei Y; Jiang YZ; Qian WH
PLoS One; 2014; 9(3):e92079. PubMed ID: 24642859
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysis.
Hu K; Lou L; Ye J; Zhang S
BMJ Open; 2015 Apr; 5(4):e006404. PubMed ID: 25854964
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis.
Li B; Xiong F; Yi S; Wang S
Technol Cancer Res Treat; 2022; 21():15330338211070140. PubMed ID: 35025614
[No Abstract] [Full Text] [Related]
34. Meta-analysis of multiple hematological biomarkers as prognostic predictors of survival in bladder cancer.
Zhang L; Li L; Liu J; Wang J; Fan Y; Dong B; Zhu Z; Zhang X
Medicine (Baltimore); 2020 Jul; 99(30):e20920. PubMed ID: 32791672
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
36. Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.
Kaynar M; Yıldırım ME; Badem H; Caviş M; Tekinarslan E; Istanbulluoğlu MO; Karataş ÖF; Çimentepe E
Tumour Biol; 2014 Jul; 35(7):6601-5. PubMed ID: 24696263
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses.
Mjaess G; Chebel R; Karam A; Moussa I; Pretot D; Abi Tayeh G; Sarkis J; Semaan A; Peltier A; Aoun F; Albisinni S; Roumeguère T
Acta Oncol; 2021 Jun; 60(6):704-713. PubMed ID: 33586577
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.
Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB
Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419
[TBL] [Abstract][Full Text] [Related]
40. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
